Head-to-head · WeighScore
Measured vs Tablet Health
The verdict
Measured takes it — 75.1/100 to 47.6/100.
Measured grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Measured is a metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Measured | Tablet Health |
|---|---|---|
| WeighScore | 75.1/100 | 47.6/100 |
| Grade | C | C |
| Scorecard rank | #58 | #495 |
| Semaglutide | $119/mo (compounded) | Not disclosed |
| Tirzepatide | $219/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #58 · C
Strengths
- Membership includes 1:1 nutrition support and board-certified provider care
- Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
- Insurance or cash-pay options for brand-name medications
- Oral option available (Wegovy pill); cancel-anytime membership
Where it loses points
- The headline $79 'GLP-1 Microdose' is a promotional rate off a $99 list price, is filed by the provider under longevity rather than weight loss, and is not a labelled therapeutic dose of either molecule
- Branded plans are a $49/mo membership with the medication billed separately at $149 to $449/mo
- The site never states which billing term its 'from' prices assume, though the terms allow monthly, quarterly, semi-annual and annual
- No state count is published
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #495 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.